Ownership history in Parallel Advisors, LLC · 14 quarters on record
This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in AKERO THERAPEUTICS INC COM (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,166 | -4,000 | -77.4% | 0.00% | $55K | — |
| 2025 Q2 | REDUCED | 5,166 | -3 | -0.1% | 0.01% | $276K | — |
| 2025 Q1 | REDUCED | 5,169 | -370 | -6.7% | 0.00% | $219K | — |
| 2024 Q4 | ADDED | 5,539 | +3 | +0.1% | 0.00% | $154K | — |